Invention Grant
- Patent Title: Use of periostin as a novel biomarker
- Patent Title (中): 使用骨膜素作为新生物标志物
-
Application No.: US13571211Application Date: 2012-08-09
-
Publication No.: US08592223B2Publication Date: 2013-11-26
- Inventor: Sharon Adler , Bancha Satirapoj , Ying Wang , Janine LaPage , Cynthia C. Nast
- Applicant: Sharon Adler , Bancha Satirapoj , Ying Wang , Janine LaPage , Cynthia C. Nast
- Applicant Address: US CA Torrance
- Assignee: Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
- Current Assignee: Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
- Current Assignee Address: US CA Torrance
- Agency: Weaver Austin Villeneuve & Sampson LLP
- Agent Emily M. Haliday
- Main IPC: G01N33/566
- IPC: G01N33/566

Abstract:
The invention provides, in certain embodiments, a method of assaying an indicator of, and treating, renal injury or renal disease. The method entails assaying a urine sample for periostin, wherein the presence of periostin at an elevated level indicates the presence and/or degree of renal injury or renal disease. The method also involves prescribing, initiating, or altering prophylaxis or therapy for renal injury or renal disease. Also provided, are methods of determining progression of these conditions, as well as methods of determining subjects' response to treatment.
Public/Granted literature
- US20120329886A1 USE OF PERIOSTIN AS A NOVEL BIOMARKER Public/Granted day:2012-12-27
Information query
IPC分类: